Report cover image

Global Therapeutic Protein Market Analysis and Forecast 2025-2031

Publisher APO Research, Inc.
Published Oct 20, 2025
Length 195 Pages
SKU # APRC20561320

Description

Summary

According to APO Research, The global Therapeutic Protein market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Therapeutic Protein is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Therapeutic Protein is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Therapeutic Protein is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Therapeutic Protein is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Therapeutic Protein include Eli Lilly, Baxter International, Amgen, AstraZeneca, GeneScience Pharmaceuticals, Generex Biotechnology, Genentech, Diasome Pharmaceuticals and Chugai Pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Therapeutic Protein, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Therapeutic Protein, also provides the sales of main regions and countries. Of the upcoming market potential for Therapeutic Protein, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Therapeutic Protein sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Therapeutic Protein market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Therapeutic Protein sales, projected growth trends, production technology, application and end-user industry.

Therapeutic Protein Segment by Company

Eli Lilly
Baxter International
Amgen
AstraZeneca
GeneScience Pharmaceuticals
Generex Biotechnology
Genentech
Diasome Pharmaceuticals
Chugai Pharmaceutical
Boehringer Ingelheim
Abbott Laboratories
Therapeutic Protein Segment by Type

Insulin
Human Growth Hormone
Blood Clotting Factors
Interferon
Monoclonal Antibodies
Follicle Stimulating Hormone
Erythropoietin
Therapeutic Protein Segment by Application

Pharmaceutical Companies
Healthcare Service Providers
Research Organizations
Academic Research Institutes
Therapeutic Protein Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Therapeutic Protein market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Therapeutic Protein and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Therapeutic Protein.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Therapeutic Protein in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Therapeutic Protein manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Therapeutic Protein sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

195 Pages
1 Market Overview
1.1 Product Definition
1.2 Therapeutic Protein Market by Type
1.2.1 Global Therapeutic Protein Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Insulin
1.2.3 Human Growth Hormone
1.2.4 Blood Clotting Factors
1.2.5 Interferon
1.2.6 Monoclonal Antibodies
1.2.7 Follicle Stimulating Hormone
1.2.8 Erythropoietin
1.3 Therapeutic Protein Market by Application
1.3.1 Global Therapeutic Protein Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical Companies
1.3.3 Healthcare Service Providers
1.3.4 Research Organizations
1.3.5 Academic Research Institutes
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Therapeutic Protein Market Dynamics
2.1 Therapeutic Protein Industry Trends
2.2 Therapeutic Protein Industry Drivers
2.3 Therapeutic Protein Industry Opportunities and Challenges
2.4 Therapeutic Protein Industry Restraints
3 Global Market Growth Prospects
3.1 Global Therapeutic Protein Revenue Estimates and Forecasts (2020-2031)
3.2 Global Therapeutic Protein Revenue by Region
3.2.1 Global Therapeutic Protein Revenue by Region: 2020 VS 2024 VS 2031
3.2.2 Global Therapeutic Protein Revenue by Region (2020-2025)
3.2.3 Global Therapeutic Protein Revenue by Region (2026-2031)
3.2.4 Global Therapeutic Protein Revenue Market Share by Region (2020-2031)
3.3 Global Therapeutic Protein Sales Estimates and Forecasts 2020-2031
3.4 Global Therapeutic Protein Sales by Region
3.4.1 Global Therapeutic Protein Sales by Region: 2020 VS 2024 VS 2031
3.4.2 Global Therapeutic Protein Sales by Region (2020-2025)
3.4.3 Global Therapeutic Protein Sales by Region (2026-2031)
3.4.4 Global Therapeutic Protein Sales Market Share by Region (2020-2031)
3.5 US & Canada & Mexico
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
4.1 Global Therapeutic Protein Revenue by Manufacturers
4.1.1 Global Therapeutic Protein Revenue by Manufacturers (2020-2025)
4.1.2 Global Therapeutic Protein Revenue Market Share by Manufacturers (2020-2025)
4.1.3 Global Therapeutic Protein Manufacturers Revenue Share Top 10 and Top 5 in 2024
4.2 Global Therapeutic Protein Sales by Manufacturers
4.2.1 Global Therapeutic Protein Sales by Manufacturers (2020-2025)
4.2.2 Global Therapeutic Protein Sales Market Share by Manufacturers (2020-2025)
4.2.3 Global Therapeutic Protein Manufacturers Sales Share Top 10 and Top 5 in 2024
4.3 Global Therapeutic Protein Sales Price by Manufacturers (2020-2025)
4.4 Global Therapeutic Protein Key Manufacturers Ranking, 2023 VS 2024 VS 2025
4.5 Global Therapeutic Protein Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Therapeutic Protein Manufacturers, Product Type & Application
4.7 Global Therapeutic Protein Manufacturers' Establishment Date
4.8 Market Competitive Analysis
4.8.1 Global Therapeutic Protein Market CR5 and HHI
4.8.2 2024 Therapeutic Protein Tier 1, Tier 2, and Tier 3
5 Therapeutic Protein Market by Type
5.1 Global Therapeutic Protein Revenue by Type
5.1.1 Global Therapeutic Protein Revenue by Type (2020 VS 2024 VS 2031)
5.1.2 Global Therapeutic Protein Revenue by Type (2020-2031) & (US$ Million)
5.1.3 Global Therapeutic Protein Revenue Market Share by Type (2020-2031)
5.2 Global Therapeutic Protein Sales by Type
5.2.1 Global Therapeutic Protein Sales by Type (2020 VS 2024 VS 2031)
5.2.2 Global Therapeutic Protein Sales by Type (2020-2031) & (k tons)
5.2.3 Global Therapeutic Protein Sales Market Share by Type (2020-2031)
5.3 Global Therapeutic Protein Price by Type
6 Therapeutic Protein Market by Application
6.1 Global Therapeutic Protein Revenue by Application
6.1.1 Global Therapeutic Protein Revenue by Application (2020 VS 2024 VS 2031)
6.1.2 Global Therapeutic Protein Revenue by Application (2020-2031) & (US$ Million)
6.1.3 Global Therapeutic Protein Revenue Market Share by Application (2020-2031)
6.2 Global Therapeutic Protein Sales by Application
6.2.1 Global Therapeutic Protein Sales by Application (2020 VS 2024 VS 2031)
6.2.2 Global Therapeutic Protein Sales by Application (2020-2031) & (k tons)
6.2.3 Global Therapeutic Protein Sales Market Share by Application (2020-2031)
6.3 Global Therapeutic Protein Price by Application
7 Company Profiles
7.1 Eli Lilly
7.1.1 Eli Lilly Comapny Information
7.1.2 Eli Lilly Business Overview
7.1.3 Eli Lilly Therapeutic Protein Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Eli Lilly Therapeutic Protein Product Portfolio
7.1.5 Eli Lilly Recent Developments
7.2 Baxter International
7.2.1 Baxter International Comapny Information
7.2.2 Baxter International Business Overview
7.2.3 Baxter International Therapeutic Protein Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Baxter International Therapeutic Protein Product Portfolio
7.2.5 Baxter International Recent Developments
7.3 Amgen
7.3.1 Amgen Comapny Information
7.3.2 Amgen Business Overview
7.3.3 Amgen Therapeutic Protein Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Amgen Therapeutic Protein Product Portfolio
7.3.5 Amgen Recent Developments
7.4 AstraZeneca
7.4.1 AstraZeneca Comapny Information
7.4.2 AstraZeneca Business Overview
7.4.3 AstraZeneca Therapeutic Protein Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 AstraZeneca Therapeutic Protein Product Portfolio
7.4.5 AstraZeneca Recent Developments
7.5 GeneScience Pharmaceuticals
7.5.1 GeneScience Pharmaceuticals Comapny Information
7.5.2 GeneScience Pharmaceuticals Business Overview
7.5.3 GeneScience Pharmaceuticals Therapeutic Protein Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 GeneScience Pharmaceuticals Therapeutic Protein Product Portfolio
7.5.5 GeneScience Pharmaceuticals Recent Developments
7.6 Generex Biotechnology
7.6.1 Generex Biotechnology Comapny Information
7.6.2 Generex Biotechnology Business Overview
7.6.3 Generex Biotechnology Therapeutic Protein Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Generex Biotechnology Therapeutic Protein Product Portfolio
7.6.5 Generex Biotechnology Recent Developments
7.7 Genentech
7.7.1 Genentech Comapny Information
7.7.2 Genentech Business Overview
7.7.3 Genentech Therapeutic Protein Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Genentech Therapeutic Protein Product Portfolio
7.7.5 Genentech Recent Developments
7.8 Diasome Pharmaceuticals
7.8.1 Diasome Pharmaceuticals Comapny Information
7.8.2 Diasome Pharmaceuticals Business Overview
7.8.3 Diasome Pharmaceuticals Therapeutic Protein Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Diasome Pharmaceuticals Therapeutic Protein Product Portfolio
7.8.5 Diasome Pharmaceuticals Recent Developments
7.9 Chugai Pharmaceutical
7.9.1 Chugai Pharmaceutical Comapny Information
7.9.2 Chugai Pharmaceutical Business Overview
7.9.3 Chugai Pharmaceutical Therapeutic Protein Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Chugai Pharmaceutical Therapeutic Protein Product Portfolio
7.9.5 Chugai Pharmaceutical Recent Developments
7.10 Boehringer Ingelheim
7.10.1 Boehringer Ingelheim Comapny Information
7.10.2 Boehringer Ingelheim Business Overview
7.10.3 Boehringer Ingelheim Therapeutic Protein Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Boehringer Ingelheim Therapeutic Protein Product Portfolio
7.10.5 Boehringer Ingelheim Recent Developments
7.11 Abbott Laboratories
7.11.1 Abbott Laboratories Comapny Information
7.11.2 Abbott Laboratories Business Overview
7.11.3 Abbott Laboratories Therapeutic Protein Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Abbott Laboratories Therapeutic Protein Product Portfolio
7.11.5 Abbott Laboratories Recent Developments
8 North America
8.1 North America Therapeutic Protein Market Size by Type
8.1.1 North America Therapeutic Protein Revenue by Type (2020-2031)
8.1.2 North America Therapeutic Protein Sales by Type (2020-2031)
8.1.3 North America Therapeutic Protein Price by Type (2020-2031)
8.2 North America Therapeutic Protein Market Size by Application
8.2.1 North America Therapeutic Protein Revenue by Application (2020-2031)
8.2.2 North America Therapeutic Protein Sales by Application (2020-2031)
8.2.3 North America Therapeutic Protein Price by Application (2020-2031)
8.3 North America Therapeutic Protein Market Size by Country
8.3.1 North America Therapeutic Protein Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
8.3.2 North America Therapeutic Protein Sales by Country (2020 VS 2024 VS 2031)
8.3.3 North America Therapeutic Protein Price by Country (2020-2031)
8.3.4 United States
8.3.5 Canada
9 Europe
9.1 Europe Therapeutic Protein Market Size by Type
9.1.1 Europe Therapeutic Protein Revenue by Type (2020-2031)
9.1.2 Europe Therapeutic Protein Sales by Type (2020-2031)
9.1.3 Europe Therapeutic Protein Price by Type (2020-2031)
9.2 Europe Therapeutic Protein Market Size by Application
9.2.1 Europe Therapeutic Protein Revenue by Application (2020-2031)
9.2.2 Europe Therapeutic Protein Sales by Application (2020-2031)
9.2.3 Europe Therapeutic Protein Price by Application (2020-2031)
9.3 Europe Therapeutic Protein Market Size by Country
9.3.1 Europe Therapeutic Protein Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
9.3.2 Europe Therapeutic Protein Sales by Country (2020 VS 2024 VS 2031)
9.3.3 Europe Therapeutic Protein Price by Country (2020-2031)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Netherlands
10 China
10.1 China Therapeutic Protein Market Size by Type
10.1.1 China Therapeutic Protein Revenue by Type (2020-2031)
10.1.2 China Therapeutic Protein Sales by Type (2020-2031)
10.1.3 China Therapeutic Protein Price by Type (2020-2031)
10.2 China Therapeutic Protein Market Size by Application
10.2.1 China Therapeutic Protein Revenue by Application (2020-2031)
10.2.2 China Therapeutic Protein Sales by Application (2020-2031)
10.2.3 China Therapeutic Protein Price by Application (2020-2031)
11 Asia (Excluding China)
11.1 Asia Therapeutic Protein Market Size by Type
11.1.1 Asia Therapeutic Protein Revenue by Type (2020-2031)
11.1.2 Asia Therapeutic Protein Sales by Type (2020-2031)
11.1.3 Asia Therapeutic Protein Price by Type (2020-2031)
11.2 Asia Therapeutic Protein Market Size by Application
11.2.1 Asia Therapeutic Protein Revenue by Application (2020-2031)
11.2.2 Asia Therapeutic Protein Sales by Application (2020-2031)
11.2.3 Asia Therapeutic Protein Price by Application (2020-2031)
11.3 Asia Therapeutic Protein Market Size by Country
11.3.1 Asia Therapeutic Protein Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
11.3.2 Asia Therapeutic Protein Sales by Country (2020 VS 2024 VS 2031)
11.3.3 Asia Therapeutic Protein Price by Country (2020-2031)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 Taiwan
11.3.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Therapeutic Protein Market Size by Type
12.1.1 SAMEA Therapeutic Protein Revenue by Type (2020-2031)
12.1.2 SAMEA Therapeutic Protein Sales by Type (2020-2031)
12.1.3 SAMEA Therapeutic Protein Price by Type (2020-2031)
12.2 SAMEA Therapeutic Protein Market Size by Application
12.2.1 SAMEA Therapeutic Protein Revenue by Application (2020-2031)
12.2.2 SAMEA Therapeutic Protein Sales by Application (2020-2031)
12.2.3 SAMEA Therapeutic Protein Price by Application (2020-2031)
12.3 SAMEA Therapeutic Protein Market Size by Country
12.3.1 SAMEA Therapeutic Protein Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
12.3.2 SAMEA Therapeutic Protein Sales by Country (2020 VS 2024 VS 2031)
12.3.3 SAMEA Therapeutic Protein Price by Country (2020-2031)
12.3.4 Brazil
12.3.5 Argentina
12.3.6 Chile
12.3.7 Colombia
12.3.8 Peru
12.3.9 Saudi Arabia
12.3.10 Israel
12.3.11 UAE
12.3.12 Turkey
12.3.13 Iran
12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
13.1 Therapeutic Protein Value Chain Analysis
13.1.1 Therapeutic Protein Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Therapeutic Protein Production Mode & Process
13.2 Therapeutic Protein Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Therapeutic Protein Distributors
13.2.3 Therapeutic Protein Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.